Double maintains 1 strategies that include PHAT - Phathom Pharmaceuticals, Inc.
Yahoo
FLORHAM PARK, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that members of the management team will participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8th, 2025, at 10:15 am ET. Company management will also participate in one-on-one meetings during the conference,
SeekingAlpha
Phathom Pharmaceuticals: The Clock Is Ticking On Voquezna (Downgrade)
Yahoo
FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in connection with the appointment of Steven Basta as President and Chief Executive Officer, the Company’s Board of Directors has approved the grant of inducement awards. The Board of Directors approved the grant to Mr. Basta of a non-qualified stock opt
Yahoo
FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that Steven Basta has been appointed President and Chief Executive Officer and a member of the Board of Directors, effective immediately. Mr. Basta succeeds Terrie Curran, who is stepping down as President and CEO and as a member of the Board of Directors for
Yahoo
For the first time, Thompson shares his journey living with gastroesophageal reflux disease (GERD) and experience using VOQUEZNA, as part of the new GERD IS NO JOKE campaignVOQUEZNA is a potassium competitive acid blocker (PCAB), the first and only FDA-approved treatment of its kind for both types of GERD1 A Media Snippet accompanying this announcement is available by clicking on this link. FLORHAM PARK, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a bio
SeekingAlpha
In a volatile fourth quarter, the Wasatch Ultra Growth FundâInvestor Class returned 0.94% and slightly underperformed the benchmark Russell 2000® Growth Index, which rose 1.70%.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FAT | -0.01% | $51.78M | -29.61% | 15.36% |
GBDC | -0.01% | - | - | 10.54% |
OCFT | -0.04% | $248.36M | +201.34% | 0.00% |
CORT | 0.05% | $8.84B | +226.74% | 0.00% |
ARCC | -0.05% | $15.07B | - | 8.89% |
UGP | -0.07% | $3.35B | -44.74% | 3.94% |
NTIC | -0.09% | $98.97M | -14.76% | 2.70% |
ACCD | 0.13% | $573.13M | -25.32% | 0.00% |
GEN | 0.14% | $16.65B | +22.44% | 1.92% |
CPK | 0.14% | $2.99B | +24.18% | 1.95% |
ACI | 0.14% | $13.00B | +5.65% | 2.22% |
GBTG | -0.15% | $3.56B | +24.17% | 0.00% |
CHH | 0.16% | $6.26B | +12.70% | 0.90% |
RS | 0.18% | $15.57B | -13.18% | 1.62% |
UNFI | 0.20% | $1.70B | +164.22% | 0.00% |
CHKP | -0.21% | $24.71B | +39.10% | 0.00% |
CRESY | -0.23% | $695.81M | +26.65% | 8.92% |
FUBO | 0.23% | $1.08B | +101.92% | 0.00% |
EMO | -0.23% | - | - | 7.58% |
CNC | 0.24% | $30.13B | -16.85% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
EFAA | 35.03% | $100.03M | 0% |
XBI | 32.96% | $4.76B | 0.35% |
XPH | 31.79% | $158.14M | 0.35% |
IBB | 30.23% | $5.61B | 0.45% |
GNOM | 29.53% | $47.13M | 0.5% |
VSS | 28.95% | $8.34B | 0.07% |
EEMA | 28.86% | $400.45M | 0.49% |
ARKG | 28.86% | $936.86M | 0.75% |
PTH | 28.67% | $107.91M | 0.6% |
FXB | 28.52% | $55.87M | 0.4% |
DFSI | 28.29% | $639.05M | 0.24% |
BOTZ | 28.10% | $2.36B | 0.68% |
ERTH | 27.99% | $138.98M | 0.67% |
ROBO | 27.91% | $924.80M | 0.95% |
IXUS | 27.91% | $39.99B | 0.07% |
NUDM | 27.90% | $499.35M | 0.31% |
EMXC | 27.88% | $14.60B | 0.25% |
EEMV | 27.80% | $4.14B | 0.26% |
EELV | 27.76% | $362.29M | 0.29% |
XT | 27.75% | $2.97B | 0.46% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -26.86% | $416.76M | 1.43% |
UUP | -24.14% | $325.79M | 0.77% |
BTC | -21.34% | $3.28B | 0.15% |
USDU | -19.98% | $206.96M | 0.5% |
VIXY | -19.34% | $195.31M | 0.85% |
TAIL | -15.24% | $87.65M | 0.59% |
FTXG | -11.93% | $26.06M | 0.6% |
DFNM | -11.50% | $1.51B | 0.17% |
IYK | -11.02% | $1.53B | 0.4% |
EZET | -10.60% | $22.46M | 0% |
ETHV | -10.51% | $87.97M | 0% |
FETH | -10.42% | $762.75M | 0.25% |
QETH | -10.37% | $14.36M | 0.25% |
CCOR | -10.33% | $64.12M | 1.18% |
CETH | -10.33% | $10.49M | 0% |
ETH | -10.25% | $1.29B | 0% |
ETHW | -10.24% | $178.76M | 0% |
ETHA | -10.23% | $2.27B | 0.25% |
JMST | -8.66% | $3.54B | 0.18% |
CLOI | -7.15% | $1.01B | 0.4% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
EMLP | -0.02% | $3.30B | 0.96% |
DRLL | -0.05% | $304.11M | 0.41% |
MUST | 0.06% | $406.02M | 0.23% |
FENY | -0.08% | $1.56B | 0.084% |
PZA | 0.09% | $3.00B | 0.28% |
SPHD | -0.14% | $3.55B | 0.3% |
SOYB | -0.20% | $26.08M | 0.22% |
ITM | -0.20% | $1.90B | 0.18% |
SHV | -0.26% | $20.16B | 0.15% |
VDE | 0.27% | $7.91B | 0.09% |
RSPG | 0.39% | $516.67M | 0.4% |
XBIL | 0.40% | $706.15M | 0.15% |
VTEB | 0.44% | $36.03B | 0.03% |
IYE | -0.48% | $1.33B | 0.39% |
HYMB | 0.51% | $2.75B | 0.35% |
SMB | -0.52% | $265.76M | 0.07% |
FMB | -0.53% | $2.00B | 0.65% |
WEAT | 0.60% | $115.75M | 0.28% |
NYF | -0.68% | $866.32M | 0.25% |
FSTA | 0.68% | $1.30B | 0.084% |
Current Value
$5.231 Year Return
Current Value
$5.231 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BTCT | -30.50% | $20.15M | +14.57% | 0.00% |
VZ | -22.21% | $188.34B | +4.44% | 5.84% |
SO | -17.81% | $100.14B | +28.63% | 3.09% |
TSN | -17.65% | $21.91B | +8.55% | 3.09% |
T | -17.63% | $201.99B | +59.80% | 3.85% |
ED | -17.59% | $38.69B | +21.90% | 2.95% |
NOC | -16.02% | $74.14B | +12.07% | 1.60% |
D | -15.66% | $47.91B | +15.63% | 4.73% |
TMUS | -15.66% | $302.06B | +62.05% | 1.14% |
IDA | -15.35% | $6.43B | +30.23% | 2.81% |
MO | -15.31% | $96.57B | +35.61% | 6.83% |
CHD | -14.95% | $26.66B | +5.00% | 1.03% |
CMS | -14.48% | $22.33B | +25.86% | 2.76% |
KMB | -13.99% | $47.39B | +13.36% | 3.37% |
PEP | -13.90% | $204.52B | -12.12% | 3.52% |
AEE | -13.88% | $27.24B | +37.85% | 2.66% |
KR | -13.50% | $48.68B | +16.46% | 1.77% |
MGEE | -13.49% | $3.40B | +18.68% | 1.91% |
TAP | -13.40% | $12.55B | -9.08% | 2.86% |
GO | -13.31% | $1.34B | -48.40% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ROIV | 33.61% | $7.19B | -12.42% | 0.00% |
SPNS | 33.58% | $1.54B | -13.89% | 2.15% |
WAY | 32.53% | $6.43B | +73.63% | 0.00% |
COHR | 30.50% | $10.47B | +13.63% | 0.00% |
SYRE | 30.45% | $933.38M | -55.31% | 0.00% |
ALC | 30.38% | $45.80B | +10.12% | 0.29% |
HPE | 30.04% | $21.17B | -11.38% | 3.68% |
RGNX | 29.84% | $353.11M | -65.19% | 0.00% |
DNLI | 29.41% | $2.00B | -29.07% | 0.00% |
KIDS | 29.41% | $638.98M | -3.94% | 0.00% |
JBGS | 28.95% | $1.35B | +6.60% | 4.52% |
IDYA | 28.72% | $1.43B | -61.21% | 0.00% |
VERI | 28.67% | $105.69M | -63.26% | 0.00% |
ALDX | 28.65% | $317.95M | +28.31% | 0.00% |
IRON | 28.60% | $1.68B | +59.11% | 0.00% |
PDSB | 28.51% | $52.43M | -68.61% | 0.00% |
SITM | 28.50% | $3.73B | +78.22% | 0.00% |
MPWR | 28.12% | $28.27B | -9.11% | 1.04% |
AUTL | 27.88% | $417.82M | -71.40% | 0.00% |
IMVT | 27.79% | $2.79B | -47.34% | 0.00% |